1. Home
  2. NGNE
  3. NGNE News

Latest Neurogene Inc. (NGNE) News on November 8, 2024

Neurogene to Present Interim Clinical Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome

Business Wire

18 days ago

Neurogene to Present Interim Clinical Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome

Share on Social Networks: